This educational summit, supported by an independent grant from OM/Vifor Pharma, brought together experts in the field of urology and gynaecology from Europe and Latin America to meet and discuss the cutting edge management of patients suffering from recurrent urinary tract infections (rUTIs). The meeting included plenary lectures as well as workshops and interactive sessions, allowing delegates and presenters to debate the most pressing international and local issues in the field.
The physiological and anatomical changes associated with pathological and non-pathological conditions, such as pregnancy, can modify both the risk of contracting a UTI and the recommended treatment. Risk factors also evolve across the lifespan of a patient affecting the management of UTIs. Here we discuss specific challenges in disease management across a number of patient subgroups at higher risk of UTI.
Please view the full content in the pdf above.